The concentrations of FABP4 (38.1 ± 4.4 ng/mL versus 18.6 ± 2.6 ng/mL, p < 0.001) and FFA (2910.9 ± 280.2 μEq/L versus 1415.6 ± 150.6 μEq/L, p < 0.001) were significantly higher in the AMI group compared to the stable AP group. The gene discussed is FABP4; the disease is alkaline phosphatase measurement.